Lamotrigine Extended Release Tablet
Product Images NDC 49884-604

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lamotrigine Extended Release (NDC 49884-604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lamotrigine Er Tabs 1)

FDA Label Image

Lamotrigine Er Tablets 300 mg Label (Lamotrigine Er Tabs 10)

Lamotrigine Er Tablets 300 mg Label (Lamotrigine Er Tabs 10)
This is a medication called Lamotrig, it comes in the form of extended-release tablets of 300mg, and it's meant to be taken once a day. It comes in a bottle of 30 tablets and is only available with a prescription. The usual dosage should be consulted in the package insert. It's important to keep it out of reach of children and store it between 20°C to 25°C. The accompanying medication guide should be dispensed to each patient. Manufacturing of this medication is done in China.*
FDA Label Image

This Is Figure 1 (Lamotrigine Er Tabs 2)

This Is Figure 1 (Lamotrigine Er Tabs 2)
The text is a table that shows the percentage of patients who were given Placebo and Lamotigine drugs. It also includes some numbers and characters that do not make sense. Therefore, a useful description cannot be generated.*
FDA Label Image

Fig1 (Lamotrigine Er Tabs 3)

Fig1 (Lamotrigine Er Tabs 3)
The text represents a graph that compares the responder rate improvement and worsening of patients who took Plasebo (N=120) and ZZ Gimotigie ER (n=1185). The graph shows that for patients who took ZZ Gimotigie ER, there was a 100% responder rate (equal or greater) improvement, while for those who took Plasebo, it was 75%. The graph also indicates 50% worsening for Plasebo users but does not provide the corresponding data for ZZ Gimotigie ER users. There are no further details available in the given text.*
FDA Label Image

Tablet Images (Lamotrigine Er Tabs 4)

Tablet Images (Lamotrigine Er Tabs 4)
This is a description of different dosages of tablets for Lamotrigine Extended-Release, a medication used to treat seizures. The available dosages are 25mg, 50mg, 100mg, and 200mg. The first line may include a batch or reference number.*
FDA Label Image

Lamotrigine Er Tablets 25 mg Label (Lamotrigine Er Tabs 5)

Lamotrigine Er Tablets 25 mg Label (Lamotrigine Er Tabs 5)
This is a medication guide for the drug Lamotrigine. The tablets are extended-release, to be taken once a day, and each tablet contains 25mg of Lamotrigine. It is important to read the medication guide before use, and store the tablets between 20-25°C. The recommended dosage is available on the package insert. Keep this drug out of reach of children. The manufacturer is located in Chestnut Ridge, NY 10877 USA, and the tablets are made in China.*
FDA Label Image

Lamotrigine Er Tablets 50 mg Label (Lamotrigine Er Tabs 6)

Lamotrigine Er Tablets 50 mg Label (Lamotrigine Er Tabs 6)
This is a description of a medication with the NDC code 49884-562-11. It is an extended-release tablet called Lamotrig, with a strength of 50mg. The medication guide must be dispensed with each patient who is given this prescription. The dosage will depend on the patient and the condition being treated. Caution is advised to ensure the correct product is dispensed. The medication should be stored at a controlled room temperature out of reach of children. The tablet is manufactured in China by Par Pharmacet.*
FDA Label Image

Lamotrigine Er Tablets 100 mg Label (Lamotrigine Er Tabs 7)

Lamotrigine Er Tablets 100 mg Label (Lamotrigine Er Tabs 7)
Once-a-Day Lamotrigine Extended-Release Tablets in 100mg, with the NDC number 49884-563-1, are prescription drugs that need to be dispensed with a medication guide for each patient. They are film-coated and have to be kept out of reach of children at temperatures between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F), according to USP Controlled Room Temperature. The usual dosage can be found in the package insert. The tablets are manufactured in China by Zhejiang Hual for Par Pharmaceutical of Chestnut Ridge, NY.*
FDA Label Image

Lamotrigine Er Tablets 200 mg Label (Lamotrigine Er Tabs 8)

Lamotrigine Er Tablets 200 mg Label (Lamotrigine Er Tabs 8)
This is a medication with NDC (National Drug Code) 49884-564-11. It is a once-a-day extended-release tablet of lamotrigine with a strength of 200mg. The usual dosage is indicated in the package insert. It should be kept out of reach of children and stored at a temperature range between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The manufacturer is Par Pharmaceutical and its distributor is Zhejiang Huahai Pharmaceutical Co., Ltd.*
FDA Label Image

Lamotrigine Er Tablets 250 mg Label (Lamotrigine Er Tabs 9)

Lamotrigine Er Tablets 250 mg Label (Lamotrigine Er Tabs 9)
This is a description of a medication called "Lamotri gine" in the form of extended-release tablets. Each tablet contains 250mg of lamotrigine. The packaging is a box containing 30 tablets. The medication guide should be provided to each patient. The usual dosage is mentioned in the package insert. The tablets should be stored between 20°C to 25°C (68°F to 77°F) with excursions between 10°C to 30°C (59°F to 86°F) as permitted under USP Controlled Room Temperature. The manufacturer is Zhejiang Huahai Pharmaceutical Co., Ltd, Zhejiang 317024 China, for Par Pharmaceutical, Chestnut Ridge, NY 10977, USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.